{
  "permutation_id": "P12",
  "description": "AC-SINS throughout",
  "reclassification_strategy": "R5",
  "removal_strategy": "S5",
  "reclassified_ids": [
    "bavituximab",
    "bimagrumab",
    "drozitumab",
    "infliximab",
    "tremelimumab"
  ],
  "removed_ids": [
    "urelumab",
    "glembatumumab",
    "basiliximab",
    "seribantumab",
    "lirilumab",
    "ocrelizumab",
    "atezolizumab",
    "ipilimumab",
    "crenezumab",
    "benralizumab",
    "pembrolizumab",
    "tigatuzumab",
    "veltuzumab",
    "tralokinumab",
    "ganitumab",
    "otelixizumab",
    "dinutuximab",
    "radretumab",
    "siltuximab",
    "fezakinumab",
    "nivolumab",
    "muromonab",
    "otlertuzumab",
    "tovetumab",
    "rituximab",
    "rilotumumab",
    "trastuzumab",
    "tabalumab",
    "obinutuzumab",
    "daratumumab"
  ],
  "confusion_matrix": [
    [
      41,
      18
    ],
    [
      11,
      16
    ]
  ],
  "accuracy": 0.6627906976744186,
  "exact_match": false,
  "timestamp": "2025-11-03T23:11:15.013636"
}